The company is laying off 40% of its workforce and discontinuing its therapeutics division.
What 23andMe business troubles could mean for users’ genetic data
Nov 13, 2024 | 1:48 PM
The company is laying off 40% of its workforce and discontinuing its therapeutics division.
